Extracellular matrix molecules: potential targets in pharmacotherapy

H Järveläinen, A Sainio, M Koulu, TN Wight… - Pharmacological …, 2009 - ASPET
The extracellular matrix (ECM) consists of numerous macromolecules classified traditionally
into collagens, elastin, and microfibrillar proteins, proteoglycans including hyaluronan, and …

Mitotic chromosomal instability and cancer: mouse modelling of the human disease

JM Schvartzman, R Sotillo, R Benezra - Nature Reviews Cancer, 2010 - nature.com
The stepwise progression from an early dysplastic lesion to full-blown metastatic malignancy
is associated with increases in genomic instability. Mitotic chromosomal instability—the …

Personalized immunotherapy against several neuronal and brain tumors

S Kuttruff-coqui, T Weinschenk, J Fritsche… - US Patent …, 2021 - Google Patents
2014-11-12 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

Membrane fission reactions of the mammalian ESCRT pathway

J McCullough, LA Colf… - Annual review of …, 2013 - annualreviews.org
The endosomal sorting complexes required for transport (ESCRT) pathway was initially
defined in yeast genetic screens that identified the factors necessary to sort membrane …

The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities

J Boni, C Rubio-Perez, N López-Bigas, C Fillat… - Cancers, 2020 - mdpi.com
DYRK (dual-specificity tyrosine-regulated kinases) are an evolutionary conserved family of
protein kinases with members from yeast to humans. In humans, DYRKs are pleiotropic …

A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy

I Pérez de Castro, G de Cárcer, M Malumbres - Carcinogenesis, 2007 - academic.oup.com
Tumor cell proliferation is frequently associated with genetic or epigenetic alterations in key
regulators of the cell cycle. Most known oncogenes and tumor suppressors target entry into …

Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors

M Polkowski - Endoscopy, 2005 - thieme-connect.com
Background Submucosal tumor, or submucosal lesion, is an umbrella term encompassing a
variety of non-neoplastic and neoplastic conditions (both benign and malignant). Their …

Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade

N Nakamura, H Yamamoto, T Yao, Y Oda, K Nishiyama… - Human pathology, 2005 - Elsevier
Gastrointestinal stromal tumors (GISTs) have a wide spectrum of biologic behavior ranging
from benign to malignant. Risk grading based on tumor size and mitotic counts has been …

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

S Subramanian, RB West, CL Corless, W Ou, BP Rubin… - Oncogene, 2004 - nature.com
Most GISTs require oncogenic activation of the KIT or PDGFRA receptor tyrosine kinase
proteins, and the genomic mechanisms of oncogene activation are heterogeneous. Notably …

Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization

F Haller, B Kulle, S Schwager, B Gunawan… - Analytical …, 2004 - Elsevier
In quantitative reverse transcription–polymerase chain reaction (qRT–PCR), normalization
using reference genes is a common useful approach, but the validation of suitable reference …